XML 68 R33.htm IDEA: XBRL DOCUMENT v3.22.0.1
Description of Business, Organization and Liquidity - Additional Information (Detail) - USD ($)
$ / shares in Units, $ in Thousands
1 Months Ended 12 Months Ended
Jun. 01, 2021
May 23, 2021
Jun. 30, 2021
Dec. 31, 2019
Dec. 31, 2021
Dec. 31, 2020
Dec. 31, 2018
Organization Consolidation And Presentation Of Financial Statements [Line Items]              
Proceeds from issuance of initial public offering $ 167,000            
Payments of stock issuance costs $ 17,000            
Share-based compensation arrangement by share-based payment award, options, vested, number of shares         4,719,605    
Common stock shares authorized         500,000,000    
Preferred stock shares authorized         10,000,000 0  
Preferred stock par or stated value per share         $ 0.0001    
Stockholders' equity note, stock split   2.325-for-1          
Retained Earnings (Accumulated Deficit)         $ (127,487) $ (56,842)  
Cash and cash equivalents       $ 27,332 $ 284,309 $ 43,728 $ 942
I P O [Member]              
Organization Consolidation And Presentation Of Financial Statements [Line Items]              
Common stock issued in IPO, net of issuance costs of $16,995, shares 11,500,000   11,500,000        
Shares issued, price per share $ 16.00       $ 16.00    
Number of shares issued upon conversion         5,433,290    
Stock issued during period, shares, conversion of units         32,489,398    
Share-based compensation arrangement by share-based payment award, options, grants in period, net of forfeitures         4,418,874    
Over-Allotment Option [Member]              
Organization Consolidation And Presentation Of Financial Statements [Line Items]              
Stock issued during period, shares, issued for services 1,500,000            
Series A Redeemable Convertible Preferred Stock [Member]              
Organization Consolidation And Presentation Of Financial Statements [Line Items]              
Payments of stock issuance costs       $ 95,000      
Common stock par or stated value per share         $ 0.0001    
Series A Redeemable Convertible Preferred Stock [Member] | Millennium Pharmaceuticals, Inc. [Member] | The Millennium Stock Exchange Agreement [Member]              
Organization Consolidation And Presentation Of Financial Statements [Line Items]              
Conversion of stock, shares converted         9,857,143    
Convertible preferred stock, shares issued upon conversion         6,470,382